Peter Goldstraw,Kari Chansky,John Crowley,Ramon Rami-Porta,Hisao Asamura,Wilfried E.E. Eberhardt,Andrew G. Nicholson,Patti Groome,Alan Mitchell,Vanessa Bolejack,Advisory Boards International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee,Peter Goldstraw,Ramón Rami-Porta,Hisao Asamura,David Ball,David G. Beer,Ricardo Beyruti,Vanessa Bolejack,Kari Chansky,John Crowley,Frank Detterbeck,Wilfried Ernst Erich Eberhardt,John Edwards,Françoise Galateau-Sallé,Dorothy Giroux,Fergus Gleeson,Patti Groome,James Huang,Catherine Kennedy,Jhingook Kim,Young Tae Kim,Laura Kingsbury,Haruhiko Kondo,Mark Krasnik,Kaoru Kubota,Antoon Lerut,Gustavo Lyons,Mirella Marino,Edith M. Marom,Jan van Meerbeeck,Alan Mitchell,Takashi Nakano,Andrew G. Nicholson,Anna Nowak,Michael Peake,Thomas Rice,Kenneth Rosenzweig,Enrico Ruffini,Valerie Rusch,Nagahiro Saijo,Paul Van Schil,Jean-Paul Sculier,Lynn Shemanski,Kelly Stratton,Kenji Suzuki,Yuji Tachimori,Charles F. Thomas,William Travis,Ming S. Tsao,Andrew Turrisi,Johan Vansteenkiste,Hirokazu Watanabe,Yi-Long Wu,Paul Baas,Jeremy Erasmus,Seiki Hasegawa,Kouki Inai,Kemp Kernstine,Hedy Kindler,Lee Krug,Kristiaan Nackaerts,Harvey Pass,David Rice,Conrad Falkson,Pier Luigi Filosso,Giuseppe Giaccone,Kazuya Kondo,Marco Lucchi,Meinoshin Okumura,Eugene Blackstone,F. Abad Cavaco,E. Ansótegui Barrera,J. Abal Arca,I. Parente Lamelas,A. Arnau Obrer,R. Guijarro Jorge,D. Ball,G.K. Bascom,A.I. Blanco Orozco,M.A. González Castro,M.G. Blum,D. Chimondeguy,V. Cvijanovic,S. Defranchi,B. de Olaiz Navarro,I. Escobar Campuzano,I. Macía Vidueira,E. Fernández Araujo,F. Andreo García,K.M. Fong,G. Francisco Corral,S. Cerezo González,J. Freixinet Gilart,L. García Arangüena,S. García Barajas,P. Girard,T. Goksel,M.T. González Budiño,G. González Casaurrán,J.A. Gullón Blanco,J. Hernández Hernández,H. Hernández Rodríguez,J. Herrero Collantes,M. Iglesias Heras,J.M. Izquierdo Elena,E. Jakobsen,S. Kostas,P. León Atance,A. Núñez Ares,M. Liao,M. Losanovscky,G. Lyons,R. Magaroles,L. De Esteban Júlvez,M. Mariñán Gorospe,B. McCaughan,C. Kennedy,R. Melchor Íñiguez,L. Miravet Sorribes,S. Naranjo Gozalo,C. Álvarez de Arriba,M. Núñez Delgado,J. Padilla Alarcón,J.C. Peñalver Cuesta,J.S. Park,H. Pass,M.J. Pavón Fernández,M. Rosenberg,E. Ruffini,V. Rusch,J. Sánchez de Cos Escuín,A. Saura Vinuesa,M. Serra Mitjans,T.E. Strand,D. Subotic,S. Swisher,R. Terra,C. Thomas,K. Tournoy,P. Van Schil,M. Velasquez,Y.L. Wu,K. Yokoi

Abstract:The IASLC Staging and Prognostic Factors Committee has collected a new database of 94,708 cases donated from 35 sources in 16 countries around the globe. This has now been analysed by our statistical partners at Cancer Research And Biostatistics and, in close collaboration with the members of the committee proposals have been developed for the T, N, and M categories of the 8th edition of the TNM Classification for lung cancer due to be published late 2016. In this publication we describe the methods used to evaluate the resultant Stage groupings and the proposals put forward for the 8th edition.

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: proposals for the revision of the N descriptors in the forthcoming 8th edition of the …

The Lymph node ratio optimizes staging in patients with small intestinal neuroendocrine tumors.

Validation of the 8th Edition Nodal Staging and Proposal of New Nodal Categories for Future Editions of the TNM Classification of Non-Small Cell Lung Cancer

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer

Validation Study for the N Descriptor of the Newly Proposed Ninth Edition of the TNM Staging System Proposed by the International Association for the Study of Lung Cancer

The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revisions of the T-Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer

The IASLC Mesothelioma Staging Project: Proposals for the 'N' descriptors in the forthcoming 9th edition of the TNM classification for Pleural Mesothelioma

Role of Pathologic Single-N and Multiple-N Descriptors in Resected Non-Small Cell Lung Cancer

Recommended changes for the 8th edition of the TNM classification for lung cancer-the findings of a single-institution evaluation

Validation of the Eighth Edition of the TNM Staging System for Lung Cancer in 2043 Surgically Treated Patients With Non–small-cell Lung Cancer

The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer

Improving accuracy in nodal staging of oral cancer: Proposal of a new system

Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis

The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: Proposals for the N and the M Components for the Forthcoming (ninth) Edition of the TNM Classification of Malignant Tumors

Number of Positive Lymph Nodes is Superior to LNR and LODDS for Predicting the Prognosis of Pancreatic Neuroendocrine Neoplasms

Comparison of the TNM9th and 8th editions for localized and locally advanced anal squamous cell carcinoma treated nonsurgically and proposal of a new stage grouping system

Number of involved nodal stations: a better lymph node classification for clinical stage IA lung adenocarcinoma

Comparative Analysis of Methodologies for Predicting Overall Survival in Patients with Non‐small Cell Lung Cancer Based on the Number and Rate of Resected Positive Lymph Nodes: A Study Based on the SEER Database for 2010 Through 2019

Validation of the 9th edition of the TNM staging system for non-small cell lung cancer with lobectomy in stage IA–IIIA

Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?